Drug details

Tobi (tobramycin)

type of Aminoglycosides

Tobi (tobramycin) is an antibiotic used to treat lung infections in patients with cystic fibrosis.

The drug is often used to treat Cystic fibrosis .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• wheezing,
• cough,
• little or no urination,
• muscle weakness,
• trouble breathing,
• chest tightness,
• ringing in your ears,
• spinning sensation,
• weak or shallow breathing,
• hearing problems,
• shortness of breath
• hoarse voice,
• severe dizziness,
• tiredness, and
• new or worsening breathing problems,
• balance problems,
• swelling of your feet or ankles,

The following drugs are related to Tobi, either as a replacement or used together:

• Atrovent HFA (ipratropium bromide inhalation aerosol)
• Bethkis (tobramycin inhalation solution)
• Creon (pancrelipase capsules)
• Creon 10 (pancrelipase delayed-released capsules)
• Creon 20 (pancrelipase delayed-released capsules)
• Pulmozyme (dornase alfa)
• Rolvedon (eflapegrastim-xnst for injection)
• Fylnetra (pegfilgrastim-pbbk injection, for subcutaneous use)
• Kalydeco (ivacaftor)
• Pancreaze (pancrelipase microtablets)
• Ultresa (pancrelipase)
• Pertzye (pancrelipase)